Biotech

All Articles

Pfizer, Valneva show lyme ailment shot efficient for 2nd booster

.Pfizer and also Valneva might have concerning 2 additional years to hang around before they help ma...

Fierce Biotech Editor-in-Chief Ayla Ellison Talks Shop with Michelle Benz on the Future of Biotech.

.Let's study a conversation along with Ayla Ellison, Brutal Biotech Managing Editor and Michelle Ben...

New data demonstrate how Bayer's asundexian failed to stop strokes

.Bayer suspended the stage 3 trial for its own aspect XIa inhibitor asundexian behind time in 2014 a...

Sanofi's tolebrutinib fails 2 of 3 late-stage MS trials

.Sanofi is still set on taking its own a number of sclerosis (MS) med tolebrutinib to the FDA, execs...

Galapagos' stock up as fund shows intent to shape its evolution

.Galapagos is actually coming under added pressure from real estate investors. Having built a 9.9% c...

Cell- focused Sana scoops initial CSO-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of considerable leadership hirings, firings and...

Allist pays Jacobio $21M, landing task in Mandarin KRAS nationality

.Shanghai Allist Pharmaceuticals has acquired on its own a starring role in China's KRAS market, pay...

ReNeuron leaving intention exchange after missing out on fundraising goal

.ReNeuron has participated in the lengthy checklist of biotechs to leave London's objective stock ex...

MBX files for IPO to take opposition to Ascendis into stage 3

.MBX Biosciences has actually contributed to the recent spurt of IPO filings. The biotech, which sub...

FDA grows probing in to Lykos' MDMA trials: WSJ

.For Lykos Therapeutics and the company's prospective MDMA-assisted therapy for trauma (POST-TRAUMAT...